HUP9904104A3 - Derivates from piperidine-keto acid,their preparation and use - Google Patents

Derivates from piperidine-keto acid,their preparation and use

Info

Publication number
HUP9904104A3
HUP9904104A3 HU9904104A HUP9904104A HUP9904104A3 HU P9904104 A3 HUP9904104 A3 HU P9904104A3 HU 9904104 A HU9904104 A HU 9904104A HU P9904104 A HUP9904104 A HU P9904104A HU P9904104 A3 HUP9904104 A3 HU P9904104A3
Authority
HU
Hungary
Prior art keywords
derivates
piperidine
preparation
keto acid
keto
Prior art date
Application number
HU9904104A
Other languages
English (en)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HUP9904104A2 publication Critical patent/HUP9904104A2/hu
Publication of HUP9904104A3 publication Critical patent/HUP9904104A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU9904104A 1996-10-15 1997-09-23 Derivates from piperidine-keto acid,their preparation and use HUP9904104A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19642591A DE19642591A1 (de) 1996-10-15 1996-10-15 Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung

Publications (2)

Publication Number Publication Date
HUP9904104A2 HUP9904104A2 (hu) 2000-05-28
HUP9904104A3 true HUP9904104A3 (en) 2001-01-29

Family

ID=7808858

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904104A HUP9904104A3 (en) 1996-10-15 1997-09-23 Derivates from piperidine-keto acid,their preparation and use

Country Status (24)

Country Link
US (1) US6380220B1 (hu)
EP (1) EP0934273A1 (hu)
JP (1) JP2001501955A (hu)
KR (1) KR20000049130A (hu)
CN (1) CN1239950A (hu)
AR (1) AR009379A1 (hu)
AU (1) AU736754B2 (hu)
BG (1) BG103338A (hu)
BR (1) BR9711908A (hu)
CA (1) CA2268917A1 (hu)
CO (1) CO4930264A1 (hu)
CZ (1) CZ126899A3 (hu)
DE (1) DE19642591A1 (hu)
HR (1) HRP970549A2 (hu)
HU (1) HUP9904104A3 (hu)
IL (1) IL129089A0 (hu)
NO (1) NO991761D0 (hu)
NZ (1) NZ334979A (hu)
PL (1) PL332720A1 (hu)
RU (1) RU2189974C2 (hu)
SK (1) SK38599A3 (hu)
TR (1) TR199900819T2 (hu)
WO (1) WO1998016512A1 (hu)
ZA (1) ZA979175B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19817459A1 (de) 1998-04-20 1999-10-21 Basf Ag Neue heterozyklische substituierte Amide, Herstellung und Anwendung
AU3818799A (en) * 1998-04-20 1999-11-08 Basf Aktiengesellschaft Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
JP4782924B2 (ja) * 1998-04-20 2011-09-28 アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 新規の置換アミド、それらの製造および使用
CN1297441A (zh) 1998-04-20 2001-05-30 Basf公司 用作为钙蛋白酶抑制剂的杂环取代酰胺
US6117870A (en) * 1998-11-12 2000-09-12 Fujirebio Kabushiki Kaisha Cyclic amide derivatives
AU6936500A (en) * 1999-08-24 2001-03-19 Regents Of The University Of California, The Non-quinoline inhibitors of malaria parasites
CZ20011872A3 (cs) 1999-09-29 2002-03-13 Ortho-Mcneil Pharmaceutical, Inc. Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
WO2002002546A1 (fr) 2000-06-30 2002-01-10 Seikagaku Corporation Amides d'acide carboxylique, azides et amino-alcools et procedes de preparation de $g(a)-ceto amides a l'aide de ces derniers
DE10114762A1 (de) * 2001-03-26 2002-10-02 Knoll Gmbh Verwendung von Cysteinprotease-Inhibitoren
JP2004529918A (ja) 2001-04-09 2004-09-30 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド インテグリンに由来する疾患の治療のためのキナゾリンおよびキナゾリン類似化合物
JP4617449B2 (ja) 2002-07-11 2011-01-26 ヴィキュロン ファーマシューティカルズ インコーポレイテッド 抗菌活性を有するn−ヒドロキシアミド誘導体
WO2005016883A2 (en) * 2003-08-14 2005-02-24 Icos Corporation Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
JP5295976B2 (ja) 2006-12-29 2013-09-18 アボット ゲーエムベーハー ウント カンパニー カーゲー カルボキサミド化合物およびカルパイン阻害剤としてのこれらの使用
TWI453019B (zh) * 2007-12-28 2014-09-21 Abbvie Deutschland 甲醯胺化合物
TWI519530B (zh) 2009-02-20 2016-02-01 艾伯維德國有限及兩合公司 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
US8236798B2 (en) 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
US8598211B2 (en) 2009-12-22 2013-12-03 Abbvie Inc. Carboxamide compounds and their use as calpain inhibitors IV
US9051304B2 (en) 2009-12-22 2015-06-09 AbbVie Deutschland GmbH & Co. KG Carboxamide compounds and their use as calpain inhibitors V
WO2012076639A1 (en) 2010-12-09 2012-06-14 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors v
RU2014144285A (ru) 2012-04-03 2016-05-27 Эббви Дойчланд Гмбх Унд Ко. Кг Карбоксамидные соединения и их применение в качестве ингибиторов кальпаина v
EP3426674A4 (en) 2016-03-09 2019-08-14 Blade Therapeutics, Inc. CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
AU2017292646A1 (en) 2016-07-05 2019-02-07 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
CA3038331A1 (en) 2016-09-28 2018-04-05 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
JP7293129B2 (ja) 2017-06-01 2023-06-19 エーザイ・アール・アンド・ディー・マネジメント株式会社 Pde9阻害剤を含む医薬組成物
CA3061884A1 (en) 2017-06-01 2019-10-29 Eisai R&D Management Co., Ltd. Lewy body disease therapeutic agent containing pyrazoloquinoline derivative
AU2019242387A1 (en) * 2018-03-28 2020-11-19 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011850A2 (en) * 1990-12-28 1992-07-23 Cortex Pharmaceuticals, Inc. Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
WO1992012140A1 (en) * 1990-12-28 1992-07-23 Georgia Tech Research Corporation Peptides ketoamides, ketoacids, and ketoesters
CA2071621C (en) 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
JPH09500087A (ja) * 1992-06-24 1997-01-07 コーテックス ファーマシューティカルズ インコーポレイテッド カルパイン活性の増大に関連した健康障害の抑制及び処置におけるカルパイン阻害剤の使用法
US5541290A (en) * 1993-06-24 1996-07-30 Harbeson; Scott L. Optically pure calpain inhibitor compounds

Also Published As

Publication number Publication date
JP2001501955A (ja) 2001-02-13
HRP970549A2 (en) 1998-08-31
AR009379A1 (es) 2000-04-12
CO4930264A1 (es) 2000-06-27
NZ334979A (en) 2001-02-23
AU4777097A (en) 1998-05-11
PL332720A1 (en) 1999-10-11
CZ126899A3 (cs) 1999-07-14
CA2268917A1 (en) 1998-04-23
BG103338A (bg) 2000-01-31
NO991761L (no) 1999-04-14
HUP9904104A2 (hu) 2000-05-28
ZA979175B (en) 1999-04-14
RU2189974C2 (ru) 2002-09-27
IL129089A0 (en) 2000-02-17
US6380220B1 (en) 2002-04-30
DE19642591A1 (de) 1998-04-16
KR20000049130A (ko) 2000-07-25
CN1239950A (zh) 1999-12-29
SK38599A3 (en) 2000-04-10
TR199900819T2 (xx) 1999-06-21
EP0934273A1 (de) 1999-08-11
AU736754B2 (en) 2001-08-02
WO1998016512A1 (de) 1998-04-23
BR9711908A (pt) 1999-08-24
NO991761D0 (no) 1999-04-14

Similar Documents

Publication Publication Date Title
HUP9904104A3 (en) Derivates from piperidine-keto acid,their preparation and use
HK1078561A1 (en) Novel compounds, their use and preparation
EP0888151A4 (en) MECHANICAL BRAKE FOR RECALL
SG87776A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
HUP9904051A3 (en) 4-hetaroylpyrazol derivatives, preparation and use thereof as herbicides
HUP9903691A3 (en) Pesticidal karbanilide derivatives, preparation and use thereof
HK1034722A1 (en) Antipicornaviral compounds, their preparation and use
ZA973097B (en) Novel aspire-hydroxy acid derivatives their preparation and use
GB9608485D0 (en) Compositions, processes and uses
AUPN943096A0 (en) Descender
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
AU5557698A (en) Novel calpaines, their preparation and use
ZA9711047B (en) Formulation and use.
SI0862550T1 (en) Carboxylic acid derivatives, their preparation and their use
IL133481A0 (en) Substituted cycloheptenes, their preparation and use
GB9608487D0 (en) Compositions, processes and uses
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
NZ330551A (en) 2-aryloxy-6-aryl-3,5-difluoropyridines, their use as herbicides and their preparation thereof
ZA976592B (en) Formulation
ZA9710499B (en) Longlines
ZA975001B (en) Preparation of Alpha-fluoroketones.
HUP0002897A3 (en) Herbicidal substituted 2-benzoyl-cyclohexane-1,3-diones, preparation and use thereof
ZA979045B (en) Derivates of pentaerythrits.
HU9800542D0 (en) Epoxy-azetidinones, preparation and use thereof
IL125561A0 (en) (s)-5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-ylamine and its preparation